Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
https://doi.org/10.37489/2782-3784-myrwd-063
EDN: NSKJZY
Abstract
The 2nd revised and supplemented edition of “Pharmacovigilance” has been published. This book discusses the drug safety and pharmacovigilance systems from the viewpoint of clinical pharmacology. The history of drug safety studies is given in details. The main definitions and classifications of adverse events are presented below. A separate chapter will examine the pharmacovigilance system in the EAEU member states. The textbook is intended for students, residents, postgraduates, clinical pharmacologists, physicians of other specialties, holders of registration certificates, and researchers.
About the Author
V. I. PetrovRussian Federation
Vladimir I. Petrov — DM, Professor, Academician of the Russian Academy of Sciences, President; head Department of Clinical Pharmacology and Intensive Care; chief freelance specialist — clinical pharmacologist of the Russian Ministry of Health; President of the Association of Clinical Pharmacologists
Volgograd
Review
For citations:
Petrov V.I. Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025. Real-World Data & Evidence. 2024;4(4):53-55. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-063. EDN: NSKJZY